Does innovation in obesity drugs affect stock markets?: An event study analysis ¿La innovación en medicamentos contra la obesidad afecta a los mercados de valores?: Un análisis de estudio de eventos
Objective: This study empirically analyzes the effects of public information about the pharmaceutical R&D process on the market valuation of the sponsoring firm. We examined the market's response to scientific news and regulatory decisions about an antiobesity drug, rimonabant, and the effe...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |